NDC 70677-0152-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0152
- Requested NDC
- 70677-0152-01
- Package NDCs from labels
- 70677-0152-1, 70677-0152-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0152-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 | |
| 70677-0152-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0152 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0152-1 | ML - Milliliter | 70677-0152 | bb59880f-140d-48e5-abd1-1bd53821bd87 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ibuprofen | IBUPROFEN | NuCare Pharmaceuticals, Inc. | 463ea713-6b27-b00b-e063-6394a90a8646 | 2025-12-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | BETTER LIVING BRANDS LLC. | a3c1a61b-88fc-419c-e053-2a95a90ac0c3 | 2025-12-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | BETTER LIVING BRANDS LLC. | 8c3ca03e-0ec2-c15c-e053-2995a90ad8bd | 2025-12-18 | Warnings | WK2XYI10QM |
| Lemon | GLYCERIN | TwinMed LLC | fc88eec0-c66c-5d6d-e053-6294a90a13d2 | 2025-12-18 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | e5db46f3-043b-40ac-a89b-c90bd562e7b4 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| HZ-Chord | BAPTISIA TINCTORIA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HYDROCOTYLE ASIATICA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MEZEREUM, MORBILLINUM, NUX VOMICA, PALOONDO, PHYTOLACCA DECANDRA, SEPIA, THUJA OCCIDENTALIS, THYROIDINUM (BOVINE) | Energetix Corporation | 9685aec5-a65d-40fe-b5d7-2f13a69733bc | 2025-12-17 | Warnings | XF417D3PSL |
| Category V | IMMUNE SYSTEM BOOSTER | Vitality Works, Inc, | 0d3dd923-336c-4ccd-a344-ec49b2e80d10 | 2025-12-17 | Warnings | XF417D3PSL |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 3db0c659-cc43-45dc-8442-bc89093d94d7 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| IBUPROFEN, DIPHENHYDRAMINE HCL | IBUPROFEN, DIPHENHYDRAMINE HCL | TARGET Corporation | 97e2c008-1711-dcba-e053-2995a90aa2ff | 2025-12-16 | Warnings | WK2XYI10QM |
| Ibuprofen PM | IBUPROFEN, DIPHENHYDRAMINE HCL | KROGER COMPANY | ca5418f2-4dc0-ad31-e053-2995a90ac1d3 | 2025-12-16 | Warnings | WK2XYI10QM |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | WALGREEN COMPANY | 2789fdef-2d8e-6247-e063-6394a90a974b | 2025-12-16 | Warnings | WK2XYI10QM |
| STYE RELIEF SERUM | CARBOXYMETHYLCELLULOSE SODIUM(CMC) | Guangzhou Shimei Cosmetics Co., Ltd. | 45fa7962-b489-4613-e063-6394a90a59b0 | 2025-12-15 | Warnings | K679OBS311 |
| Gentle Eyes Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | TRP Company | 13f99af6-b7d8-a092-e063-6394a90a5daa | 2025-12-15 | Warnings | K679OBS311 |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | PDC6A3C0OX |
| equate dual pain reliever | ACETAMINOPHEN, IBUPROFEN | WALMART INC. | 09dc976b-6065-4aad-9d57-0fe5e88a722a | 2025-12-15 | Warnings | WK2XYI10QM |
| ElixirLidoFast Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | ELIXIR HEALTHCARE USA, LLC. | 45de9dfa-6c89-1eae-e063-6294a90a4dac | 2025-12-13 | Warnings | PDC6A3C0OX |
| topcare childrens ibuprofen | IBUPROFEN | Topco Associates LLC | d1bb68a6-3a29-4a4e-b4e9-413cc8d16191 | 2025-12-12 | Warnings | 197803 WK2XYI10QM |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS | MARKSANS PHARMA LIMITED | 46121a30-1361-4f2b-9f3f-3cedabd66c33 | 2025-12-12 | Warnings | WK2XYI10QM |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | DISCOUNT DRUG MART, INC. | f9dfeb0e-0d4d-7348-e053-6394a90a8aef | 2025-12-12 | Warnings | WK2XYI10QM |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | Bionpharma Inc. | 04ccc4b2-0cfd-3012-e063-6394a90afa79 | 2025-12-12 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.